ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Byooviz 10 mg / ml, Injektionslösung in Fertigspritze - 
70708001 Samsung Bioepis CH GmbH
Byooviz 10 mg / ml, Injektionslösung in Fertigspritze12.05.2026
  12.05.2026
Ranibizumab (S01LA04) 
WHO-DDD11.05.2031
 
11.99. 
B  
No 
IP 
   
k.A. 
  
7680707080012Biotechnologika
  
Composition
ranibizumabum 1.65 mg, trehalosum dihydricum, histidinum, histidini hydrochloridum monohydricum, polysorbatum 20, aqua ad iniectabile q.s. ad solutionem pro 1 ml.
Packungsbestandteile
Injection solution in prefilled syringe
 
 
Active AgentDose
Ranibizumab1.65 mg/ml
 
Inactive agents
Histidin Hydrochloride Monohydrate
Histidine
Polysorbatum 20
Trehalosum Dihydricum
Source
Data was imported : 05.06.2026 Swissmedic Registration : Sequence : Product name : Registration owner: : Product group : Index Therapeuticus (BSV) : Medication Code : Date of registration : Valid until : Package number : Show package size : Commercial Form/Unit : Swissmedic categorie. : Active Agents : Composition :
 
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home